Introduction {#sec1}
============

Chlorinated paraffins (CPs) are well-known industrial chemicals with an extensive global use, for instance, as metal-cutting fluids, flame retardants, plasticizers, and sealants.^[@ref1]^ The global production volumes of CPs are extremely high and have exceeded one million metric tons per year.^[@ref2]^ CPs are complex mixtures of polychlorinated *n*-alkanes resulting from radical reactions between chlorine and predefined homologue series of alkane hydrocarbons. Commercial CP products are traditionally divided into short-chain CPs (SCCPs, C~10--13~), medium-chain CPs (MCCPs, C~14--17~), and long-chain CPs (LCCPs, C~18--30~) based on the carbon chain lengths of the alkanes in the products.^[@ref3]^ Hence, the carbon chain length defines the "C-homologues," whereas the number of chlorine substituents implies a second series of "Cl-homologues" for each carbon chain length. The large range of isomers include everything from one chlorine substituent for each carbon chain length up to one chlorine bound to each of the carbons in the carbon chain in question.^[@ref4]^ Calculated theoretical numbers of chlorinated alkane isomers per carbon in the chain are presented in [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf). The total theoretical number of congeners for SCCPs, MCCPs, and LCCPs are approximately 7800, 120 000, and 1 100 000 000, respectively, by assuming no more than one chlorine atom bound to any carbon atom.^[@ref4]^

CPs, independent of the carbon chain length and chlorination degree, are chemically stable under general environmental^[@ref5]−[@ref7]^ and ambient^[@ref8]−[@ref10]^ conditions. However, CPs are thermolabile.^[@ref11]−[@ref14]^ They are highly lipophilic (log *K*~OW~ 4--12)^[@ref15]^ and bioaccumulative in humans^[@ref16],[@ref17]^ and wildlife.^[@ref18],[@ref19]^ These data confirm the bioavailability and retention of CPs and, accordingly, the bioaccumulativity of this class of chemicals. The bioaccumulative properties of SCCPs and MCCPs were observed early.^[@ref3]^ In contrast, LCCPs were only recently found to be bioaccumulative. LCCPs have been shown to bioaccumulate in *Daphnia magna*, similar to SCCPs and MCCPs.^[@ref20]^ LCCPs have also been detected together with SCCPs and MCCPs, as reported in human blood^[@ref21]^ and in various wildlife species.^[@ref22]^ CPs undergo long-range transport,^[@ref23]^ which is supported by CP concentrations in the Arctic as recently reviewed by Vorkamp and co-workers.^[@ref24]^ Further, they are also distributed globally in materials and goods, from which the CPs can be mobilized into indoor air and adsorbed onto particulates (dust).^[@ref25]^

The mammalian and environmental toxicities of CPs were reviewed in 2010 by El-Sayed Ali and Legler.^[@ref26]^ Already from the beginning of CP toxicity research, focus was on SCCPs and far less on MCCPs and LCCPs. Nevertheless, MCCPs appeared to be more toxic than SCCPs based on the lowest observed effect levels (LOELs) in rats.^[@ref26]^ However, in the 2019 draft risk assessment of CPs, the European Food Safety Authority (EFSA) CONTAM Panel proposed that adverse toxicity in rats was observed at lower SCCP exposure levels than of MCCPs.^[@ref27]^ In mammals, the liver, kidney, thyroid, and parathyroid glands are target organs for CP toxicity, with developmental toxicity such as MCCP-induced adverse effects on rat offspring body weight (BW) and hematological parameters being the most sensitive endpoints.^[@ref26]^ SCCPs have been identified as possibly carcinogenic to humans,^[@ref28]^ being mutagenic when highly chlorinated.^[@ref29]^ They were included as persistent organic pollutants (POPs) in 2017 according to the Stockholm Convention (Annex A).^[@ref30]^ A toxicological interaction between SCCPs and other POPs has been reported in rats, where the SCCPs and the polybrominated diphenyl ether (PBDE-47) synergistically induce metabolic activity in the liver (EROD) and decrease the serum levels of free thyroxin, a thyroid hormone.^[@ref31]^ Recent zebrafish larva tests showed pronounced neurotoxic effects of highly chlorinated SCCPs.^[@ref32]^ SCCPs can also act as immunomodulators in mice.^[@ref33]^ Furthermore, Glüge and co-workers state that the MCCPs meet the toxicity threshold defined by REACH and should be considered toxic to the environment.^[@ref34]^

As a consequence of CPs identified as potential hazardous chemicals already in the early 1980s, occurrence data for CPs in the environment, wildlife, and humans have been published.^[@ref16],[@ref35]^ However, the complexity of the CPs has been an obstacle for the chemical instrumental quantitative analysis.^[@ref36]^ Recently, advances in analytical methods have been made,^[@ref37]^ for instance, by the development of the atmospheric-pressure chemical ionization quadrupole time-of-flight high-resolution mass spectrometry (APCI-QTOF-HRMS) method.^[@ref38]^ This method allows for measurements of CP congener groups with chain lengths of C~9~--C~30~. The recent methodological achievements have led to an avalanche of occurrence reports. However, the reporting is heavily focused on SCCPs, far less on MCCPs, and rarely on LCCPs. The reported elevated levels of CPs in wildlife^[@ref18],[@ref22],[@ref39]^ and their occurrence in household dust,^[@ref9],[@ref10]^ foodstuff,^[@ref40],[@ref41]^ and other environmental matrices^[@ref5],[@ref42]^ have sparked our interest to perform an in-depth and up-to-date study on CPs in human milk.

CPs have been produced since the mid-1930s, and their POP characteristics have been known for a long time^[@ref30]^ The human biomonitoring is still limited with just a few reports on SCCPs and MCCPs in human milk and on infant exposure to these CPs via breastfeeding from UK,^[@ref43]^ Sweden,^[@ref44]^ China,^[@ref45]^ Korea, and Japan.^[@ref46]^ It should be noted that the analytical method for the CP analysis would cause greater uncertainty than other legacy POP analyses, hindering the spatial comparison from different areas of the world across several studies.^[@ref47]−[@ref49]^ The concentration of CPs in human milk reported from China varies up to 2 orders of magnitude among studies.^[@ref45],[@ref46]^ This might be due to regional differences in CP contamination, but problems of comparing results because of use of different analytical methods must not be underestimated. Thus, using the same method for CP determination is essential for spatial comparisons.

The current study performed comprehensive chemical analyses of SCCPs, MCCPs, and LCCPs in human milk samples from three cities in China, one in Sweden, and one in Norway. The objectives were (i) to assess the potential bioaccumulation of SCCPs, MCCPs, and LCCPs in human milk, (ii) to analyze the data for CP pattern differences between sampling countries, and (iii) to estimate CP intakes of infants from breastfeeding exposure and to compare the estimated CP intakes with the lowest exposure levels associated with adverse effects in animal studies (i.e., risk characterization). Human milk samples from two Chinese cities were collected just after modification of the Chinese "birth control policy." The timing of the collection enabled sampling from both first-time and second-time mothers, which thus opens up the possibility to also investigate the difference in the concentration of CPs depending on parity.

Materials and Methods {#sec2}
=====================

Human Milk Samples {#sec2.1}
------------------

Samples were collected from Shanghai, Jiaxing, and Shaoxing, located in the Yangtze River Delta (YRD), China ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)). The cities represent one mega city and two intermediate sized cities with populations of approximately 25, 5, and 1.5 million inhabitants, respectively. The other two sampling cities are located in Scandinavia, Stockholm (Sweden) and Bodø (Norway), the former with a population of 1.5 million and the latter with approximately 50 thousand inhabitants.

Sample selection and collection were based on the World Health Organization guidelines for human milk monitoring;^[@ref50]^ the samples were not pooled, and human milk from second-time mothers were also collected in two cities from China. Detailed information on the individual samples is provided in [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf). Human milk samples from China were collected by the Yangtze Environmental Specimen Bank (YESB) at the Tongji University. A total of 36 human milk samples were collected from donors from Shanghai (*n* = 10, 2015--2016), Jiaxing (*n* = 13, 2015--2016), and Shaoxing (*n* = 13, 2010). The samples from Shaoxing were all from first-time mothers (20- to 25-year old), whereas the samples from Shanghai and Jiaxing included both first- and second-time mothers (mean age: 29 and 33 years, respectively). Human milk samples from Sweden were provided by the Swedish Museum of Natural History. The samples were collected from first-time mothers (mean age: 29 years) in 2011 (*n* = 10) and 2016 (*n* = 9) at the Mother's Milk Center (MMC) at a Stockholm hospital, Södersjukhuset. Human milk from Norway (*n* = 8) was kindly provided by first-time mothers (mean age: 35 years) at Odland Health and Environment AS, Bodø, Norway based on individual informed consent.

All Chinese participants were told the objective of this study and signed the participant information and consent form. The study was approved by the Ethics Committee of China National Center for Food Safety Risk Assessment. The Norwegian sampling was part of the MISA Study, with ethical approval from REK North (2009, 1959). The Swedish milk was purchased from MMC which collects human milk to use as nutrition for prematurely born babies. MMC provided anonymous samples, and according to the Regional Ethics Board in Stockholm, ethics approval was thus not required for this part of the study.

Sample Analysis {#sec2.2}
---------------

Sample extraction and pretreatment followed the procedures of previous studies^[@ref51],[@ref52]^ with some modification. CP congener groups from C~9~H~17~Cl~3~ to C~31~H~52~Cl~14~ (C~9--31~, Cl~2--14~) were measured using direct injection dichloromethane-enhanced APCI-QTOF-HRMS (QTOF Premier, Waters, UK). SCCPs, MCCPs, and LCCPs were quantified, respectively, with 5 SCCP, 6 MCCP, and 5 LCCP reference standards ([Table S3](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)) using a deconvolution algorithm.^[@ref38]^ Detailed information on sample storage and preparation, instrumental analysis, and quantification is presented in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf).

Quality Control and Quality Assurance {#sec2.3}
-------------------------------------

CP quantification of all samples fulfilled the criterion of *R*^2^ ≥ 0.50 ([Table S4](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)).^[@ref38],[@ref53]^ Limit of detection (LOD) and limit of quantification (LOQ) of CPs were defined as mean value plus 3 times and 10 times the standard deviation (SD) of procedural blanks, respectively. LOQs of SCCPs, MCCPs, and LCCPs were 25, 32, and 3.8 ng g^--1^ fat (lipid weight), respectively. The mean recovery of the internal standard was 92 ± 7% (range: 74--104%), and the results were recovery corrected.

Statistical Analysis {#sec2.4}
--------------------

Statistical analysis was performed with SPSS (PASW statistics 18) and OriginPro 9.0. Data below LOD was replaced with zero. So far, there is a lack of standardized method for the concentrations of CPs between LODs and LOQs. Because the instrumental intensities of CPs in the samples with concentrations lower than LOQs were on average 10 times higher than the blank ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)), the recorded data between LOD and LOQ were included as measured. In order to avoid effects from extreme values, the Kruskal--Wallis test was used to test differences in congener group compositions in human milk from the different regions sampled. Because as many as 220 CP congener groups were assessed and they represent a larger number than the number of samples (*n* = 63), the Kruskal--Wallis test was also applied to select the most discriminating CP congener groups for a principal component analysis (PCA); that is, congener groups with no significant differences (*p* \> 0.05) among groups were excluded ([Table S5](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)). PCA was applied to explore the pollution pattern of samples from the different regions sampled. Pearson correlation was used to compare the congener pattern of some of the samples in this study with those in the local commercial product for source identification. The significant level for all tests were set to 5% (α = 0.05).

Estimated Daily Intake via Human Milk {#sec2.5}
-------------------------------------

A margin of exposure (MOE) approach was applied to assess the health risks of CP exposure of infants via breast milk. MOE was calculated by the use of the estimated daily intake (EDI, ng kg^--1^ BW day^--1^) and the LOEL in animal studies or lower-bound 95^th^ confidence interval benchmark dose for a 10% change in the critical effect (BMDL~10~)where *C* is the concentration of SCCPs, MCCPs, and LCCPs in human milk (ng g^--1^ fat), *M* is the daily intake from breast milk (g kg BW^--1^ day^--1^), and *R* is the lipid content of the sample (%/100). The daily human milk intake was assumed to be 750 mL d^--1^ for an infant BW of 6 kg.^[@ref54]^ Assuming a specific weight of human milk of 1 g mL^--1^, the average daily intake of human milk by an infant weighing 6 kg was estimated to be 125 g kg BW^--1^ day^--1^. The median lipid content in the human milk samples from each country in the current study was used for country-specific intake calculations.

Results and Discussion {#sec3}
======================

CP Concentrations in Chinese and Scandinavian Human Milk {#sec3.1}
--------------------------------------------------------

The maximum concentration of SCCPs and MCCPs across all human milk samples was 676 and 1260 ng g^--1^ fat, respectively, as detected in the milk from Shanghai. LCCPs were quantified in human milk for the first time, with a maximum concentration of 184 ng g^--1^ fat (Shaoxing) and a median concentration of 6.58 ng g^--1^ fat across all samples ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Median concentrations of SCCPs, MCCPs, and LCCPs in the human milk (35.0, 78.8, and 8.80 ng g^--1^ fat, respectively) from the three Chinese cities were all significantly higher than those in samples from the Scandinavian cities (median 14.0, 29.6, and 4.17 ng g^--1^ fat, respectively) (*p* \< 0.05, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). SCCP and LCCP concentrations were comparable in samples from the two Scandinavian cities, but MCCP concentrations in the Norwegian samples (median 43.1 ng g^--1^ fat) were higher than in the Swedish samples (median 27.4 ng g^--1^ fat) (*p* \> 0.05). Stockholm human milk samples originated from the years 2011 and 2016. SCCP, MCCP, and LCCP concentrations in 2016 were on average 52, 43, and 30% lower than those in 2011, respectively ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), but not statistically significant. Concentrations reported for the SCCPs in human milk from Uppsala, Sweden in human milk sampled in 1996--2010 indicate higher levels (107 ng g^--1^ fat)^[@ref44]^ than the present samples from Stockholm in 2011 and 2016, which seem to be consistent with the decreasing trends of CPs found in sediments and wildlife from Sweden.^[@ref6],[@ref22]^

![Box and whisker plot (extended to 10th and 90th percentile) of SCCP, MCCP, and LCCP concentrations (ng g^--1^ fat) in human milk from Jiaxing (*n* = 13, 2015--2019), Shanghai (*n* = 10, 2015--2019), and Shaoxing (*n* = 13, 2010) in China, Stockholm (*n* = 10 in 2011 and *n* = 9 in 2016) in Sweden, and Bodø (*n* = 8, 2014) in Norway. The dash line represents the mean concentration.](es9b06089_0001){#fig1}

###### Comparison of Concentration (ng g^--1^ fat, Median with Range) of SCCPs, MCCPs, and LCCPs in Human Milk from the Present Study with the Literature Data

                                                       lipid      chlorine   SCCP                                                      MCCP                        LCCP                         
  ---------------------- ------------ ---------------- ---------- ---------- --------------------------------------------------------- --------------------------- --------------------------- ---------------------------
  **Shanghai**           **China**    **2015--2016**   **3.29**   **53.3**   **35.0(\<LOD-676)**                                       **70.1(38--1260)**          **10.5** **(\<LOD-56.9)**   **this study**
  **Jiaxing**            **China**    **2015--2016**   **3.85**   **54.1**   **28.6(\<LOD-642)**                                       **63.0(\<LOD-547)**         **5.23(\<LOD-18.4)**        **this study**
  **Shaoxing**           **China**    **2010**         **3.79**   **53.4**   **37.9(\<LOD-124)**                                       **121(38--187)**            **14.6(4.90--184)**         **this study**
  12 provinces (urban)   China        2007             3.5                   681 (170--6150)                                           60.4 (18.7--350)                                        Xia et al.^[@ref45]^
  16 provinces (urban)   China        2011             3.7                   733 (131--16100)                                          64.3 (22.3--1501)                                       Xia et al.^[@ref45]^
  8 provinces (rural)    China        2007             3.7                   303 (68--1580)                                            35.7 (9--139)                                           Xia et al.^[@ref54]^
  16 provinces (rural)   China        2011             3.7                   360 (66--2310)                                            45.4 (10--146)                                          Xia et al.^[@ref54]^
  Beijing                China        2007--2009                             (\<20--54)                                                                                                        Cao et al.^[@ref46]^
  Hebei                  China        2014--2015       2.2                   1.46 (0.21--16.2)                                                                                                 Yang et al.^[@ref75]^
  **Stockholm**          **Sweden**   **2011**         **3.85**   **52.1**   **15.6(\<LOD-24.1)**                                      **37.3** **(\<LOD-77.7)**   **4.28(\<LOD-21.4)**        **this study**
  **Stockholm**          **Sweden**   **2016**         **4.56**   **53.0**   **\<LOD** **(\<LOD-27.8)**                                **21.0(\<LOD-60.0)**        **2.80(\<LOD-9.34)**        **this study**
  **Bodø**               **Norway**   **2014**         **4.74**   **52.6**   **10.2**[c](#t1fn3){ref-type="table-fn"}**(\<LOD-120)**   **43.1(\<LOD-311)**         **4.26(\<LOD-29.0)**        **this study**
  Quebec                 Canada                                              (11.0--17.0)                                                                                                      Tomy^[@ref76]^
  Baden-Wurttemberg      Germany      2004--2005                             120 (49--275)[d](#t1fn4){ref-type="table-fn"}                                                                     Reth et al.^[@ref77]^
  Lancaster              UK           2001--2002                             180 (49--820)                                             21 (6.2--320)                                           Thomas et al.^[@ref43]^
  Uppsala                Sweden       1996--2010       3.1                   112 (45--157)                                             15 (1.1--30)                                            Darnerud et al.^[@ref44]^
  Seoul                  Korea        2007--2010                             \<20                                                                                                              Cao et al.^[@ref46]^
  Busan                  Korea        2008--2009                             \<20                                                                                                              Cao et al.^[@ref46]^
  Kyoto                  Japan        2009--2010                             \<20                                                                                                              Cao et al.^[@ref46]^

Mean value.

LOD of SCCPs, MCCPs, and LCCPs are 12, 16, and 1.1 ng g^--1^ fat in this study, respectively.

Average value of \<LOD and 20.4 ng g^--1^ fat.

Sum of SCCPs and MCCPs. For concentrations of individual samples, see [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf).

Notably, LCCPs were detected in 86% of the human milk samples analyzed. The highest concentrations of LCCPs were detected in Shaoxing with a median concentration of 14.6 (range: 4.90--184) ng g^--1^ fat, followed by Shanghai, 10.5 (range: \<LOD-56.9) ng g^--1^ fat. The LCCPs contributed to 1.9--20% of the ΣCPs in human milk analyzed in the current study ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)). In a recent study, LCCPs were also detected in human whole blood from Shenzhen, China, with a mean concentration of 150 (range: 20--520) ng g^--1^ fat,^[@ref21]^ indicating that LCCPs are taken up by humans. LCCPs have also recently been reported in wildlife from the YRD and from Scandinavia at concentrations of 14--10 000 and 6.0--1200 ng g^--1^ fat, respectively.^[@ref18],[@ref22]^

MCCP concentrations in Chinese milk in the current study (\<LOD-1260 ng g^--1^ fat) are comparable to concentrations reported in previous studies in urban areas, sampled between 2007 and 2011, with median concentrations of 60.4 (range: 18.7--350) and 64.3 (range: 22.3--1500) ng g^--1^ fat, respectively ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref45]^ In contrast, they are higher than the concentrations reported in the milk from the UK (median: 21, range: 6.2--320 ng g^--1^ fat),^[@ref43]^ Sweden (median: 15, range: 1.1--30 ng g^--1^ fat),^[@ref44]^ and rural areas in China in 2011 (median: 45.4, range: 10--150 ng g^--1^ fat) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref54]^ In the current study, MCCPs contributed 48--57 and 65--71% to the total CP concentration in the Chinese cities and in Stockholm/Bodø, respectively. MCCPs were in general the most abundant CP groups except in Jiaxing, where the proportion of SCCPs (50%) was slightly higher than MCCPs (48%) ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)). A recent study also found that MCCPs were the dominant CPs in human serum from Australia and that there was an increase in MCCP levels from 2004 to 2015.^[@ref55]^

The concentration of SCCPs measured in Chinese human milk in the present work is 1 or 2 orders of magnitude lower than previously reported with median concentrations of 733 and 360 ng g^--1^ fat in human milk in urban and rural areas from China in 2011, respectively.^[@ref45],[@ref54]^ However, it is higher than in human milk from Beijing sampled in 2007--2009 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref46]^ As visualized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, the mean level of SCCPs in China was comparable to concentrations reported in human milk from the UK that had been sampled in 2001--2002^[@ref43]^ and from Uppsala (Sweden) on samples taken between 1996 and 2010.^[@ref44]^ Differences in the sampling site, the sampling year, and the parity of mothers may partly explain the concentration differences among studies. For example, the concentrations of SCCPs in pooled human milk were 1 to 2 orders of magnitude different among Chinese provinces.^[@ref45]^ The bias due to the analytical technique should also be appreciated and considered when comparison of data is done, given that recent interlaboratory studies on the analysis of SCCPs showed considerably high variation between the different methods applied.^[@ref37]^

In comparison to other POPs reported in human milk after 2000,^[@ref56]^ CP concentrations detected in our study ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) are lower than the median values of the DDT metabolite *p*,*p*′-DDE in human milk reported from China and Sweden (range of medians: 100--3100 and 50--110 ng g^--1^ fat, respectively). The levels of CPs in our study are roughly comparable or slightly lower than reported concentrations of polychlorinated biphenyls (PCBs). For example, median concentrations of ΣPCBs in human milk reported from China, Sweden, and Norway were in the range of 10--210, 80--140, and 100--200 ng g^--1^ fat, respectively. However, average CP levels in human milk in our study were significantly higher than the ΣPBDEs. The median levels of PBDEs reported from China, Sweden, and Norway were in the range of 2.2--7.1, 1.9--3.2, and 1.9--3.2 ng g^--1^ fat, respectively, whereas the SCCP, MCCP, and LCCP median and range concentrations are as shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The CP levels in human milk mirror not only high production volumes of the CPs in China but also general exposures to these pollutants present in food and ambient environments, such as air and indoor dust.^[@ref25]^

Assessment of Intake of CPs via Human Milk {#sec3.2}
------------------------------------------

Using the observed concentrations of CPs in human milk, the EDIs ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}) were calculated and then compared with the LOELs ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}). The EFSA CONTAM Panel reported a lower 95% confidence interval benchmark dose for a 10% change in the critical adverse effects (BMDL~10~) of 2.3 and 36 mg kg BW^--1^ day^--1^ for SCCPs and MCCPs, respectively, based on modelling of kidney effects in rodent studies.^[@ref27]^ In parallel, a report from the Environment and Climate Change Canada (ECCC) suggested LOELs of 6 and 71 mg kg BW^--1^ day^--1^ for MCCPs and LCCPs, respectively, also based on effects on BW (MCCPs) and inflammatory effects (LCCPs) in rodent studies.^[@ref57]^ In the current study, we applied both the BMDL~10~ from EFSA and the LOEL from ECCC for risk characterization of infant CP exposure. The 50th and 90th percentiles of SCCP, MCCP, and LCCP concentrations in human milk from each country (China, Sweden, and Norway) were considered, and the results are presented in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}.

###### EDI \[ng (kg BW)^−1^ day^--1^\] of SCCPs, MCCPs, and LCCPs via Breastfeeding of Infants and MOE (Dimensionless) between the Lowest Doses Reported To Cause Adverse Toxicological Effects in Animals \[LOEL, ng (kg BW)^−1^ day^--1^\] and EDIs[a](#t2fn1){ref-type="table-fn"}

                                                               China       Sweden      Norway
  ----------------------------------------------------- ------ ----------- ----------- -----------
  lipid content (%)                                     3.81   4.07        4.74         
  **Conc (ng g^−1^ fat)**                                                              
  SCCPs                                                 90th   543         21.6        24.3
                                                        50th   35.0        12.8        10.2
  MCCPs                                                 90th   254         56.8        88.3
                                                        50th   78.8        33.3        43.1
  LCCPs                                                 90th   34.9        8.62        10.8
                                                        50th   8.80        4.89        4.26
  **EDI \[ng (kg BW)**^**--1**^**day**^**--1**^**\]**                                  
  SCCPs                                                 90th   2580        111         143
                                                        50th   166         65          60
  MCCPs                                                 90th   374         291         519
                                                        50th   121         170         253
  LCCPs                                                 90th   166         44          64
                                                        50th   42          25          25
  **MOE (EU)**                                                                         
  SCCPs                                                 90th   891         20 700      16 100
  MCCPs                                                        96 300      124 000     69 400
  **MOE (EU)**                                                                         
  SCCPs                                                 50th   13 900      35 400      38 300
  MCCPs                                                        298 000     212 000     142 000
  **MOE (Canada)**                                                                     
  MCCPs                                                 90th   4960        20 600      11 600
  LCCPs                                                        428 000     1 610 000   1 120 000
  **MOE (Canada)**                                                                     
  MCCPs                                                 50th   16 000      35 200      23 700
  LCCPs                                                        1 680 000   2 830 000   2 830 000

The BMDL~10~ value for SCCPs and MCCPs proposed by EFSA is 2.3 and 36 mg (kg BW)^−1^ day^--1^, respectively.^[@ref27]^ The LOEL value for MCCPs and LCCPs, respectively, proposed by ECCC is 6 and 71 mg (kg BW)^−1^ day^--1^.^[@ref57]^

The median EDI of CPs via human milk for Chinese, Swedish, and Norwegian infants, respectively, was 166, 65, and 60 ng kg BW^--1^ day^--1^ for SCCPs, 374, 170, and 253 ng kg BW^--1^ day^--1^ for MCCPs, and 42, 25, and 25 ng kg BW^--1^ day^--1^ for LCCPs. The EDI for MCCPs was comparable to previous data in China in 2007 and 2011 (median: 212 and 152 ng kg BW^--1^ day^--1^, respectively).^[@ref54]^ EFSA reported the EDIs of SCCPs and MCCPs in pooled human milk from 11 European countries, with a range of 60--445 and \<25--514 ng kg BW^--1^ day^--1^, respectively, for average milk consumption.^[@ref27]^ For comparison, we further calculated the EDIs ([Table S6](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)) using mean concentrations of CPs in our study and the same parameters given in EFSA (2019):^[@ref27]^ infant BW of 6.1 kg, average daily milk consumption of about 800 mL, high consumption of 1 200 mL, and milk's fat content of 3.5%. The ranges of SCCP and MCCP intake (average milk consumption) in our study were 58.7--570 and 153--669 ng kg BW^--1^ day^--1^, respectively ([Table S6](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)), which were generally similar to the EFSA calculation. This is due to the similar range in average concentrations of CPs used in the EFSA and our calculation, with Sweden in the lower range and China in the upper range in our study. The use of pooled samples or mean CP concentrations does not take into account the variation in concentrations within the population. Notably, for infants from China in our study, the 90th EDI of SCCP (2580 ng kg BW^--1^ day^--1^) was about 15 times higher than the median EDI in this group of infants. Such variation of CP intake among individuals highlights the necessity for dietary assessment using individual human milk samples instead of pooled samples in order to get a more comprehensive picture of breastfeeding CP intake in the studied population, which, however, requires more organizing efforts for large-scale assessments.

To compare the calculated EDI with the LOEL value obtained from the toxicological studies, as determined by EFSA and ECCC,^[@ref27],[@ref57]^ a total safety factor of 1000 was applied, using a factor of 10 for intraspecies variation, 10 for interspecies variation, and 10 for lack of data on carcinogenicity and only data from subchronic exposure.^[@ref57]^ A health concern was assumed if the ratio of LOEL/EDI, that is, MOE ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}), was below the safety factor (1000). In [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, it is shown that for the majority of scenarios, the MOE (90th percentile) was 1--2 orders of magnitude greater than 1000, indicating that there are no appreciable health concerns regarding SCCP, MCCP, and LCCP exposure via breastfeeding. However, the MOE (90th percentile) of SCCPs for Chinese infants (891) was lower than 1000, indicating a health concern for SCCP exposure. For Chinese infants from some other provinces, the MOE of SCCPs was as low as 143 based on previous studies^[@ref45],[@ref54]^ using pooled human milk samples.

It should be noted that the daily human milk intake was set to 750 mL day^--1^, and an infant BW of 6 kg was assumed for all three countries in the EDI calculations.^[@ref54]^ Using average values for milk intake and BW does not take into account the variability in the infant population, thus not giving the full picture of the EDI variability. The LOELs applied included other exposure windows than lactational exposure, which adds to the uncertainty of the comparisons between EDIs and LOELs. For instance, in certain cases, LOELs were based on exposure of adult rodents, and since exposure of contaminants during infancy may be a more sensitive window of exposure, such LOELs may underestimate the toxicity. Finally, possible additive effects due to coexposures of SCCPs, MCCPs, and LCCPs have not been considered, which is a likely scenario based on the structural similarities of the CPs. The CP exposure also adds to the total POP exposures from human milk,^[@ref56]^ but assessing possible health risks with cumulative exposure to the total POP mixture in human milk is beyond the possibilities in the current study because POPs other than CPs were not included in the present study. In the risk assessment of cumulative exposure to chemicals, substances may be grouped based on, for instance, common mechanisms of action/toxicity pathways or common toxic effects.^[@ref58]^ The critical toxic effects of CPs in the risk assessments of EFSA^[@ref27]^ and ECCC^[@ref57]^ \[kidney effects, growth retardation, and immunotoxic response (inflammation)\] are shared with several other POPs, such as perfluoroalkyl acids, polychlorinated dibenzo-*p*-dioxins and furans, and PCBs.^[@ref59],[@ref60]^ Consequently, studies where the whole range of POPs are measured in human milk samples from different human populations around the world are needed in order to enable risk assessment of cumulative POP exposure among different populations of breast-fed infants. The results of the cumulative POP exposure risk assessment should then be weighed against the well-known beneficial health effects of breastfeeding^[@ref61]^ in a full health risk-benefit assessment of breastfeeding.

Parity Difference {#sec3.3}
-----------------

Breastfeeding is considered to be an important route of elimination of POPs, and therefore it is expected that the body burden and also the concentration in the milk will decrease with parity.^[@ref62]−[@ref64]^ To examine whether this is the case for CPs, collection of human milk samples of first- and second-time mothers from Shanghai and Jiaxing, China was conducted, which was possible because the government abolished the "birth control policy" and imposed the "two-child policy." Concentrations of CPs in human milk from Shanghai and Jiaxing between 2015 and 2016 are presented in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. SCCP, MCCP, and LCCP concentrations in human milk from first-time mothers were generally higher than those from second-time mothers, except for LCCPs from Jiaxing, which could be due to their concentrations being close to background levels. Caution should be applied in the interpretation of these results, as each mother group includes only four to eight individual human milk samples, and thus the statistical power is not high enough to detect significant differences. Several other factors such as BMI and weight gain during pregnancy could also influence the results. Finally, firm evidence for lower levels of CPs in human milk after giving birth to a second child can only be obtained with paired samples, that is, the same mothers donate milk as they nurse both their first and second child.

###### Difference of CP Concentrations between First- and Second-Time Mothers in Shanghai and Jiaxing, China (2015--2016)

                               Shanghai      Jiaxing                 
  ------- -------------------- ------------- --------- ------------- --------------------------------------
  SCCPs   first-time mother    238 ± 167     5.16      352 ± 157     5.29[a](#t3fn1){ref-type="table-fn"}
          second-time mother   46.2 ± 14.5             66.4 ± 34.6    
  MCCPs   first-time mother    283 ± 241     3.65      181 ± 70.3    1.48
          second-time mother   77.4 ± 19.1             123 ± 88.2     
  LCCPs   first-time mother    16.3 ± 10.6   1.43      2.54 ± 1.66   0.33
          second-time mother   11.4 ± 3.36             7.60 ± 2.84    
  CPs     first-time mother    537 ± 387     3.98      536 ± 227     2.72
          second-time mother   135 ± 33.9              197 ± 115      

*p* \< 0.05. Shanghai: no. of first-time mothers = 6 and no. of second-time mothers = 4; Jiaxing: no. of first-time mothers = 5 and no. of second-time mothers = 8; Unit: average ± SD (ng g^--1^ fat), first/second (dimensionless).

Carbon and Chlorine Profiles {#sec3.4}
----------------------------

CPs with carbon chain length as long as C~27~ were observed in the current study, although C~\>22~ CPs were less abundant than C~9--22~ CPs. Mean relative abundances of C-homologue profiles (C~9--27~) of human milk from the five cities are shown in [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf), and their congener group patterns (C~9--22~) are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. In general, C~14~ was the most abundant C homologue among all CPs detected, followed by C~11~ and C~15~, and the most abundant C homologue of LCCPs was C~18~.

![Average CP congener group patterns, carbon chain length C~9--22~, and chlorine number Cl~2--14~ in human milk from Jiaxing (2015--2016), Shanghai (2015--2016), Shaoxing (2010) (China), Stockholm (2011 and 2016) (Sweden), and Bodø (2014) (Norway).](es9b06089_0002){#fig2}

C~11~ and C~14~ were the most abundant C-homologues of SCCPs and MCCPs, respectively, in human milk from the two Scandinavian cities in the present work. Similar carbon profiles were also found in milk from the UK.^[@ref43]^ The milk samples from Shanghai and Jiaxing showed a relative abundance of C~14~ comparable to C~10~ and C~11~. The CP homologues, C~10~, C~11~, and C~14~, have been shown to be the most abundant C-homologues of SCCPs and MCCPs in other previous studies^[@ref43],[@ref45]^ on human milk. In a study by Xia et al.,^[@ref54]^ for example, SCCPs were dominated by C~10~ CPs and MCCPs by C~14~ CPs.

The carbon pattern found in human milk from Shanghai in the current study was slightly different from the carbon pattern found in wildlife (e.g., fish and snake) from the same sampling area, where C~14~ was dominating among the CP congeners, followed by C~13~ and C~15~.^[@ref18]^ For comparison, C~11~ and C~13~ were the major carbon chains in the urban soil from Shanghai.^[@ref65]^

The Cl-homologue series of CPs in human milk are presented in [Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf). CPs with 2--14 chlorine substituents were present (Cl~2--14~). Similar mean chlorine contents were observed in the human milk samples analyzed, that is, 53.3--54.1% in the Chinese human milk and 52.1--53.0% in the Scandinavian samples. Cl-homologues with Cl~4--7~ were the most abundant congeners among the SCCPs, regardless of the sampling site and time. For MCCPs, a slight difference was observed between China and the Scandinavian countries; Cl~6--7~ was the major congener in the Chinese human milk, whereas Cl~5--6~ was more abundant in the Scandinavian human milk. The chlorine profile in the Chinese human milk is similar to the chlorine profiles observed in previous studies in China, where Cl~6--7~ and Cl~7--8~ showed the highest abundance for SCCPs and MCCPs, respectively.^[@ref45],[@ref54]^ The pattern also resembles the pattern seen in urban soil from the Shanghai area, predominated by Cl~5--7~ for SCCPs and Cl~7--8~ for MCCPs.^[@ref65]^ The CP congener group pattern found in Scandinavian milk samples is comparable to the profiles reported in wildlife and sediments from the same area.^[@ref22],[@ref66]^

Regional CP Contamination Patterns {#sec3.5}
----------------------------------

The congener group data presented herein ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) makes it possible to discuss both regional and some individual human milk contamination patterns. Accordingly, all Chinese mothers had resided in their local area for the most recent 10 years or more. The Swedish mothers had lived in Sweden most of their life as also the mothers from Bodø ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)). It is therefore possible to examine the pollution pattern of CPs based on individual results by PCA to examine if there is a difference in the pattern between the regions ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Concentrations relative to the total concentration were used to study the differences in the patterns rather than the total concentration. The confidence ellipses were used to test for differences between the Chinese and Scandinavian samples. The first and second principal components contributed to 38 and 33% of total variance, respectively. Based on the PCA plot, the human milk samples can be divided into several groups.

![PCA of relative abundances of 11 selected CP congener groups in human milk from Jiaxing (2015--2016), Shanghai (2015--2016), Shaoxing (2010), Stockholm (2011 and 2016), and Bodø (2014). The left dotted circles represent the 75 and 50% confidence intervals of the normal distribution for Scandinavian samples, respectively, as also the right dotted circles for the Chinese samples.](es9b06089_0003){#fig3}

Twenty-five out of 27 samples from the Scandinavian countries were located in an ellipse representing the 50% confidence interval of a bivariate normal distribution of the two first principal components. Total CP concentrations of these 25 samples ranged from \<LOD to 120 ng g^--1^ fat (average 52 ng g^--1^ fat). The vector loading factors showed that C~14--15~Cl~3--5~ contributed the most to the separation seen in the PCA plot. These samples can be considered to represent a general CP exposure level and congener group patterns in the Scandinavian countries.

Samples from Shaoxing and Shanghai and some of the samples from Jiaxing were grouped above the Scandinavian samples in the PCA plot. Thirty out of 36 samples of Chinese origin were located in a circle representing the 50% confidence interval of normal distribution. The vector loading factors showed that the SCCP congener groups (such as C~10~Cl~5~, C~11~Cl~4~, and C~13~Cl~8~) and the MCCP congener groups C~14~Cl~6--7~ contribute to the separation seen in the PCA plot. Total CP concentrations of these 30 samples ranged from 22 to 370 ng g^--1^ fat (mean 142 ng g^--1^ fat), which on average was approximately 3 times higher than those in the Scandinavian ellipse. These samples were considered as representative for the background CP pollution pattern in the YRD, although a minor difference on loading factors can be observed, in which C~14~ contributes more to Shaoxing than to Jiaxing or Shanghai samples (cf. [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)).

Ellipses of CP patterns in the PCA plot seem to be a mirror of different productions/importations and use of CPs in the YRD and Scandinavian regions. Nowadays, the global production of CPs exceeds 1 000 000 tons/year, and China is the largest CP producer and consumer in the world.^[@ref2]^ Many Chinese CP products do not differentiate between SCCPs, MCCPs, or LCCPs and may consist of C~10--20~ CPs.^[@ref67]^ In the European Union (EU), the production and use of SCCPs have been restricted during the last decades,^[@ref2]^ leading to smaller manufacturing volumes and import, with SCCPs contributing 1500--2500 tons/year (until 2007)^[@ref44]^ and MCCPs and LCCPs contributing 10 000--100 000 tons/year.^[@ref68]^ The Norwegian Ministry of the Environment banned the sale and use of SCCPs in 2002.^[@ref69]^ The Swedish government has tried to decrease the import and use of CPs since the 1990s. According to a report from the Swedish Chemicals Agency, the use of SCCPs has declined by 95% from 1998 to 2010 in Sweden, and the pattern of CPs shifted to M/LCCPs.^[@ref70]^ However, manufactured products from China may contain CPs used for the Chinese market.^[@ref71]^ How this is influencing the global trade of CPs is unclear.

The results in the current study show a number of participants with specific CP contamination patterns, which are considered as outliers. Two samples from Norway (sample ID: Bodø-2 and Bodø-6, [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)) were outside the circle representing the 50% confidence interval of normal distribution for Scandinavian countries. The total concentrations of CPs were 240 and 310 ng g^--1^ fat for Bodø-2 and Bodø-6, respectively, which were higher than the background concentration in the Scandinavian countries suggested above (mean 52 ng g^--1^ fat). Similar results were found in six samples from China with high total CP concentrations compared to the background concentration in the Chinese regions (mean 142 ng g^--1^ fat); Jiaxing-5 (720 ng g^--1^ fat), Jiaxing-9 (880 ng g^--1^ fat), Jiaxing-10 (980 ng g^--1^ fat), Jiaxing-12 (720 ng g^--1^ fat), Shaoxing-1 (2000 ng g^--1^ fat), and Shaoxing-6 (870 ng g^--1^ fat). The loading from the PCA plot in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} showed that the distribution of these samples is primarily attributed to the congener of C~10--11~Cl~4--6~. This indicates that there might be a pollution source for CPs, in particular for SCCPs in Jiaxing, which releases CPs to the environment during production, application, and potential disposal.

The individual CP congener group pattern for Bodø-6 from Norway is presented in [Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf). For comparison, the congener pattern in one of the commercial products (MP57, [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)) used in Europe is also presented. A significant correlation (*R*^2^ = 0.94, *p* \< 0.01) was observed between MP57 and Bodø-6, strongly suggesting that the exposure of CPs in Bodø-6 is attributed to this particular CP product. This was also the case for Jiaxing-12 and Shaoxing-12 from YRD, China, with a significant correlation with YS CP-52 (a CP commercial product used in YRD, *R*^2^ = 0.89, *p* \< 0.01, [Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)) and MP52 (*R*^2^ = 0.91, *p* \< 0.01, [Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf)), respectively. However, information from the questionnaire showed that there is no apparent difference between the mothers regarding diet, occupation, or migration. It is indicated that these samples with extremely high concentrations as well as specific CP congener group patterns, compared to background concentration of both China and Scandinavia, may have specific exposure source(s) of CPs. The results provide a more detailed picture of CP contamination and illustrate the importance and advantages of performing individual analysis on CPs compared to pooled sample analyses.

Regulatory Implications {#sec3.6}
-----------------------

MCCPs are not yet included as POPs in the Stockholm Convention even though they apparently fulfill the criteria according to the Stockholm Convention. In accordance with what is shown in the present study and elsewhere (cf. above), LCCPs should also be handled as SCCPs and MCCPs and be included as POPs in the Stockholm Convention. The cumulated data on CPs, including LCCPs, show contamination far from production sites (e.g., Sweden and Norway), indicating not only long-range transport but also leakages from materials and goods to indoor and ambient environments. In addition, our data shows human milk concentrations of the LCCPs up to 15 ng g^--1^ fat (median) in the Chinese samples with individual samples above 100 ng g^--1^ fat. In the Scandinavian human milk, the concentrations of LCCPs were lower with median values of 2.6--4.3 ng g^--1^ fat, which are similar to levels reported in human milk for *penta*-BDEs and *octa*-BDEs at the time of regulation by the EU in 2003.^[@ref72]^ This implies that it is time to act. The Chinese levels of LCCPs were in general higher than the PBDE concentrations at the time when the PBDEs were considered as POPs. For example, the median LCCP level in human milk from Shanghai was 10.5 ng g^--1^ fat (range: \<LOD-56.9 ng g^--1^ fat, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), whereas the PBDEs' was 7.8 ng g^--1^ fat (range: 1.8--26.7 ng g^--1^ fat, in 2007).^[@ref73]^

Finally, the structural resemblance of the CPs, independent of the chain length and chlorination degree, is high enough to handle all CPs as one class of chemicals. Past, more recent, and present data clearly point to prompt action against all CPs by intergovernmental bodies (United Nations Environment Programme through the Stockholm Convention) and EU through REACH. This is also supported by precautionary action according to the EU law.^[@ref74]^

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acs.est.9b06089](https://pubs.acs.org/doi/10.1021/acs.est.9b06089?goto=supporting-info).Materials and methods; number of CP positional isomers; sample information and raw data; reference standards; pattern reconstruction results; test statistics of Kruskal--Wallis; EDIs; sampling map; instrumental intensities of CPs in the blank and in the samples; S/M/LCCP profiles, carbon profiles; chlorine profiles; and comparisons of congener group patterns ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.est.9b06089/suppl_file/es9b06089_si_001.pdf))
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